GeneDx Holdings Retained Earnings (Accumulated Deficit) 2020-2024 | WGS
GeneDx Holdings retained earnings (accumulated deficit) from 2020 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
| GeneDx Holdings Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024 | $-1,352 |
| 2023 | $-1,300 |
| 2022 | $-1,124 |
| 2021 | $-575 |
| 2020 | $-330 |
| 2019 | $0 |
| GeneDx Holdings Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-1,352 |
| 2024-09-30 | $-1,358 |
| 2024-06-30 | $-1,350 |
| 2024-03-31 | $-1,320 |
| 2023-12-31 | $-1,300 |
| 2023-09-30 | $-1,274 |
| 2023-06-30 | $-1,232 |
| 2023-03-31 | $-1,185 |
| 2022-12-31 | $-1,124 |
| 2022-09-30 | $-816 |
| 2022-06-30 | $-738 |
| 2022-03-31 | $-652 |
| 2021-12-31 | $-575 |
| 2021-09-30 | $-535 |
| 2021-06-30 | $-85 |
| 2021-03-31 | $-98 |
| 2020-12-31 | |
| 2020-09-30 | |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.739B | $0.305B |
| GeneDx Holdings Corp. is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. GeneDx Holdings Corp., formerly known as Sema4 Holdings Corp., is based in STAMFORD, Conn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $140.708B | 26.39 |
| Elevance Health (ELV) | United States | $84.816B | 10.94 |
| CVS Health (CVS) | United States | $76.534B | 9.51 |
| Cencora (COR) | United States | $54.103B | 18.81 |
| DiDi Global (DIDIY) | China | $21.367B | 32.43 |
| Natera (NTRA) | United States | $20.793B | 0.00 |
| BioMerieux (BMXMF) | France | $15.263B | 0.00 |
| Solventum (SOLV) | United States | $12.720B | 13.47 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.739B | 0.00 |
| Revvity (RVTY) | United States | $11.399B | 19.62 |
| CochLear (CHEOY) | Australia | $11.361B | 0.00 |
| ICON (ICLR) | Ireland | $11.346B | 10.55 |
| Doximity (DOCS) | United States | $11.282B | 58.67 |
| Viatris (VTRS) | United States | $10.317B | 3.54 |
| Avantor (AVTR) | United States | $9.063B | 13.17 |
| Medpace Holdings (MEDP) | United States | $8.914B | 23.68 |
| HealthEquity (HQY) | United States | $8.389B | 41.27 |
| Sonic Healthcare (SKHHY) | Australia | $8.349B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.074B | 13.86 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| Bausch + Lomb (BLCO) | Canada | $4.156B | 24.50 |
| BrightSpring Health Services (BTSG) | United States | $4.049B | 37.48 |
| Sotera Health (SHC) | United States | $3.758B | 21.35 |
| Surgery Partners (SGRY) | United States | $2.939B | 38.22 |
| Alignment Healthcare (ALHC) | United States | $2.780B | 0.00 |
| Concentras Parent (CON) | United States | $2.743B | 15.85 |
| Organon (OGN) | United States | $2.194B | 2.33 |
| Premier (PINC) | United States | $2.087B | 14.29 |
| Ardent Health Partners (ARDT) | United States | $2.077B | 8.85 |
| Progyny (PGNY) | United States | $1.858B | 40.91 |
| PACS (PACS) | United States | $1.669B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.650B | 30.71 |
| Teladoc Health (TDOC) | United States | $1.337B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.239B | 9.42 |
| Agilon Health (AGL) | United States | $1.118B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.011B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.898B | 14.03 |
| AMN Healthcare Services Inc (AMN) | United States | $0.830B | 7.77 |
| Embecta (EMBC) | United States | $0.731B | 4.92 |
| Nutex Health (NUTX) | United States | $0.696B | 10.59 |
| QDM (QDMI) | Hong Kong, SAR China | $0.691B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.535B | 0.00 |
| Enhabit (EHAB) | United States | $0.530B | 43.62 |
| Auna S.A (AUNA) | Luxembourg | $0.510B | 13.51 |
| Sonida Senior Living (SNDA) | United States | $0.510B | 0.00 |
| LifeMD (LFMD) | United States | $0.387B | 0.00 |
| SBC Medicals (SBC) | United States | $0.363B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.362B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.202B | 0.00 |
| Oncology Institute (TOI) | United States | $0.200B | 0.00 |
| Beauty Health (SKIN) | United States | $0.184B | 0.00 |
| DocGo (DCGO) | United States | $0.153B | 25.00 |
| Sera Prognostics (SERA) | United States | $0.089B | 0.00 |
| So-Young (SY) | China | $0.087B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.083B | 0.00 |
| OncoCyte (OCX) | United States | $0.079B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.071B | 0.00 |
| KindlyMD (KDLY) | United States | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| Biodesix (BDSX) | United States | $0.053B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.037B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| ModivCare (MODV) | United States | $0.017B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |